690 related articles for article (PubMed ID: 24286179)
1. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
2. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
Palliyil B; Lebo DB; Patel PR
AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
[TBL] [Abstract][Full Text] [Related]
3. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films.
Täuber A; Müller-Goymann CC
Int J Pharm; 2015 Jul; 489(1-2):73-82. PubMed ID: 25895717
[TBL] [Abstract][Full Text] [Related]
4. In vitro model of infected stratum corneum for the efficacy evaluation of poloxamer 407-based formulations of ciclopirox olamine against Trichophyton rubrum as well as differential scanning calorimetry and stability studies.
Täuber A; Müller-Goymann CC
Int J Pharm; 2015 Oct; 494(1):304-11. PubMed ID: 26276254
[TBL] [Abstract][Full Text] [Related]
5. Skin uptake and clearance of ciclopirox following topical application.
Nair AB; Singh K; Al-Dhubiab BE; Attimarad M; Harsha S; Alhaider IA
Biopharm Drug Dispos; 2013 Dec; 34(9):540-9. PubMed ID: 24123146
[TBL] [Abstract][Full Text] [Related]
6. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
Shaikh KS; Chellampillai B; Pawar AP
Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
[TBL] [Abstract][Full Text] [Related]
7. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
[TBL] [Abstract][Full Text] [Related]
8. Topical delivery of acyclovir and ketoconazole.
Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
[TBL] [Abstract][Full Text] [Related]
9. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
10. Submicron polymeric particles prepared by vibrational spray-drying: Semisolid formulation and skin penetration/permeation studies.
Beber TC; Andrade DF; Kann B; Fontana MC; Coradini K; Windbergs M; Beck RC
Eur J Pharm Biopharm; 2014 Nov; 88(3):602-13. PubMed ID: 25078859
[TBL] [Abstract][Full Text] [Related]
11. Effect of propylene glycol on the skin penetration of drugs.
Carrer V; Alonso C; Pont M; Zanuy M; Córdoba M; Espinosa S; Barba C; Oliver MA; Martí M; Coderch L
Arch Dermatol Res; 2020 Jul; 312(5):337-352. PubMed ID: 31786711
[TBL] [Abstract][Full Text] [Related]
12. Comparison of rheological properties, follicular penetration, drug release, and permeation behavior of a novel topical drug delivery system and a conventional cream.
Lauterbach A; Müller-Goymann CC
Eur J Pharm Biopharm; 2014 Nov; 88(3):614-24. PubMed ID: 25460145
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway.
Simonetti LD; Gelfuso GM; Barbosa JC; Lopez RF
Eur J Pharm Biopharm; 2009 Sep; 73(1):90-4. PubMed ID: 19442727
[TBL] [Abstract][Full Text] [Related]
14. Copaiba Oil: Chemical Composition and Influence on In-vitro Cutaneous Permeability of Celecoxib.
Quinones OG; Abranches RP; Nakamura MJ; de Souza Ramos MF; Riemma Pierre MB
Curr Drug Deliv; 2018; 15(3):357-366. PubMed ID: 28847273
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
[TBL] [Abstract][Full Text] [Related]
16. Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and Ginkgo biloba extracts vehiculated in cosmetic formulations.
dal Belo SE; Gaspar LR; Maia Campos PM; Marty JP
Skin Pharmacol Physiol; 2009; 22(6):299-304. PubMed ID: 19786823
[TBL] [Abstract][Full Text] [Related]
17. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream.
Saeheng S; Nosoongnoen W; Varothai S; Sathirakul K
Drug Dev Ind Pharm; 2013 Sep; 39(9):1372-7. PubMed ID: 23057672
[TBL] [Abstract][Full Text] [Related]
18. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention.
da Silva ER; de Freitas ZM; Gitirana Lde B; Ricci-Júnior E
Drug Dev Ind Pharm; 2011 May; 37(5):569-75. PubMed ID: 21128702
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib.
Senna TD; Mata Dos Santos HA; Kibwila DM; Leitao AC; Santos Pyrrho AD; de Padula M; Rosas EC; Padua TA; Lara MG; Riemma Pierre MB
Curr Drug Deliv; 2017; 14(7):992-1004. PubMed ID: 28124617
[TBL] [Abstract][Full Text] [Related]
20. Is Vitamin D
D'Angelo Costa GM; Sales de Oliveira Pinto CA; Rodrigues Leite-Silva V; Rolim Baby A; Robles Velasco MV
AAPS PharmSciTech; 2018 Jul; 19(5):2418-2425. PubMed ID: 29869312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
